Although there is no clear industry regulation with regards to DNA, drug and alcohol testing in the UK, we believe that it is matter of time before this happens.
As a result, BioClinics are committed to meeting any future challenges in the sector by achieving industry leading standards through internationally recognised certification and accreditation:
September 2016 - Congratulations to the BioClinics team again on successfully passing the external audit with flying colours - zero non-conformance and zero observations. Very positive comments from the two auditors with regards to quality and control and using the ISO standards to drive the business forward.
Pictured here from left to right is a CQS Lead Auditor and Assessor for ISO 27001, Beth Fair Lawton - Clinical Operations Manager at BioClinics, Jemma Major - Quality Assurance Manager at BioClinics, and CQS Auditor for ISO 9001 and 14001.
This standard is based on a number of quality management principles including a strong customer focus, the motivation and implication of top management, the process approach and continual improvement.
Is designed to ensure the selection of adequate and proportionate security controls that protect information assets and give confidence to clients and all interested parties.
Is applicable to any organisation that wishes to establish, implement, maintain and improve an environmental management system, to assure itself of conformity with its stated environmental policy.
BioClinics ISO Standards are audited for the provision of DNA, drug and alcohol testing.
RISQS, formerly known as Achilles Link-up, has been developed to provide a service for the qualification of suppliers for all products and services that are procured by the industry.
RISQS supports Network Rail, LUL/Transport for London, passenger, light rail and freight train operators, rolling stock organisations, main infrastructure contractors and other rail products and services providers in the management of supply chain risk. RISQS is an independent, third party qualification assessment of a supplier’s capability to supply products and services.
BioClinics have demonstrated compliance to RISQS via audit for the provision of drug and alcohol testing.
Achilles UVDB is the community for the UK utilities industry. It enables the utilities sector to use Achilles' proven supplier pre-qualification system to manage risk within the supply chain and comply with EU regulations.
Launched in 1996, Achilles UVDB is the largest Achilles community that is also used by the airports and ports sector. Achilles UVDB is managed by a Steering Group comprising of utility buyers to drive industry best practice.
BioClinics are registered with UVDB for the provision of drug and alcohol testing.